Update on Non-Alcoholic Steatohepatitis, an Issue of Clinics in Liver Disease

Volume 27-2
Herausgeber: Younossi, Zobair M

• Gebundenes Buch

Produktbeschreibung

In this issue, guest editors bring their considerable expertise to this important topic. * Contains 20 practice-oriented topics, including metabolic syndrome associated with NASH; genetic markers and comorbidities predisposing to NASH and progressive liver disease; the role of bariatric surgery and endobariatric surgery in NASH; future treatment options and regimens for NAFLD; and more.  * Provides in-depth clinical reviews on non-alcoholic steatohepatitis, offering actionable insights for clinical practice.  * Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews. 

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• The Clinics: Internal Medicine
• Verlag: Elsevier - Health Sciences Division
• Seitenzahl: 240
• Erscheinungstermin: 12. April 2023
• Englisch
• Abmessung: 226mm x 154mm x 18mm
• Gewicht: 736g
• ISBN-13: 9780323960564
• ISBN-10: 0323960561
• Artikelnr.: 68062721

Inhaltsangabe

Nonalcoholic Fatty Liver Disease: Disease Burden and Disease Awareness
Metabolic Syndrome and Its Association with Nonalcoholic Steatohepatitis
Hepatic Outcomes of Nonalcoholic Fatty Liver Disease Including Cirrhosis
and Hepatocellular Carcinoma
Changings and Challenges in Liver Transplantation for Nonalcoholic Fatty
Liver Disease/Steatohepatitis
Extrahepatic Outcomes of Nonalcoholic Fatty Liver Disease: Cardiovascular
Diseases
Extrahepatic Outcomes of Nonalcoholic Fatty Liver Disease:
Nonhepatocellular Cancers
Update on Nonalcoholic Steatohepatitis: Sarcopenia and Nonalcoholic Fatty
Liver Disease
Nonalcoholic Fatty Liver Disease in Asia, Africa, and Middle East Region
Nonalcoholic Fatty Liver Disease in Latin America and Australia
Pathogenetic Pathways in Nonalcoholic Fatty Liver Disease: An Incomplete
Jigsaw Puzzle
Genetic Markers Predisposing to Nonalcoholic Steatohepatitis
Role of Liver Biopsy in Clinical Trials and Clinical Management of
Nonalcoholic Fatty Liver Disease
Roles of Radiological Tests in Clinical Trials and the Clinical Management
of Nonalcoholic Fatty Liver Disease
Noninvasive Tests Used in Risk Stratification of Patients with Nonalcoholic
Fatty Liver Disease
Current Treatment Options, Including Diet, Exercise, and Medications: The
Impact on Histology
The Role Bariatric Surgery and Endobariatric Therapies in Nonalcoholic
Steatohepatitis
Future Treatment Options and Regimens for Nonalcoholic Fatty Liver Disease
Special Population: Lean Nonalcoholic Fatty Liver Disease
Special Population: Pediatric Nonalcoholic Fatty Liver Disease
Economic Burden and Patient-Reported Outcomes of Nonalcoholic Fatty Liver
Disease
Physicians' Use of Digital Health Interventions in the Management of
Nonalcoholic fatty liver disease
Research Priorities for Precision Medicine in Nonalcoholic fatty liver
disease